E-LIB Suche - Ergebnisse für: Shore, Neal

1

Extended Safety and Tolerability of Darolutamide for Nonmet..:

Shore, Neal D ; Gratzke, Christian ; Feyerabend, Susan...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

2

Expert Perspectives on Controversies in Metastatic Castrati..:

Bryce, Alan H. ; Crawford, E. David ; Agarwal, Neeraj...
JU Open Plus. 2 (2024) 4 - p. , 2024

Link: https://doi.org/10.1097/..

3

A global phase II randomized trial comparing oral taxane Mo..:

Vaishampayan, Ulka N. ; Keessen, Marianne ; Dreicer, Robert...
European Journal of Cancer. 202 (2024) - p. 114007 , 2024

Link: https://doi.org/10.1016/..

4

A Model‐Informed Drug Development Approach to Design a Phas..:

Sannala, Chenna Keshava Reddy ; MacLean, Carol ; Larsen, Finn...
Clinical Pharmacology in Drug Development. , 2024

Link: https://doi.org/10.1002/..

5

Novel hormone therapy and coordination of care in high-risk..:

Efstathiou, Jason A. ; Morgans, Alicia K. ; Bland, Christopher S..
Cancer Treatment Reviews. 122 (2024) - p. 102630 , 2024

Link: https://doi.org/10.1016/..

6

Correction: A multidisciplinary approach to address unmet n..:

Shore, Neal D. ; Antonarakis, Emmanuel S. ; Ross, Ashley E....
Prostate Cancer and Prostatic Diseases. , 2024

Link: https://doi.org/10.1038/..

7

Barrigel Spacer Injection Technique:

Gejerman, Glen ; Goldstein, Martin M. ; Chao, Michael...
Practical Radiation Oncology. 14 (2024) 1 - p. e57-e61 , 2024

Link: https://doi.org/10.1016/..

8

EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIE..:

Boorjian, Stephen A. ; Narayan, Vikram M. ; Master, Viraj A....
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S70 , 2024

Link: https://doi.org/10.1016/..

9

Updates on Management of Biochemical Recurrent Prostate Can..:

Cooley, Lauren Folgosa ; Srivastava, Abhishek ; Shore, Neal D.
Current Treatment Options in Oncology. , 2024

Link: https://doi.org/10.1007/..

10

Interruptions in bladder cancer care during the COVID-19 pu..:

Gore, John L. ; Follmer, Kristin ; Reynolds, Jason...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) 4 - p. 116.e17-116.e21 , 2024

Link: https://doi.org/10.1016/..

11

LONGITUDINAL CHANGES IN PATIENT-REPORTED OUTCOMES (PROs) IN..:

Freedland, Stephen J. ; Gleave, Martin ; De Giorgi, Ugo...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S18 , 2024

Link: https://doi.org/10.1016/..

12

Deep and Durable Prostate-specific Antigen Response to Daro..:

Saad, Fred ; Hussain, Maha H.A. ; Tombal, Bertrand...
European Urology. , 2024

Link: https://doi.org/10.1016/..

13

Risk Stratification of Patients with Recurrence After Prima..:

Weiner, Adam B. ; Kakani, Preeti ; Armstrong, Andrew J....
European Urology. , 2024

Link: https://doi.org/10.1016/..

14

Pembrolizumab monotherapy for high-risk non-muscle-invasive..:

Necchi, Andrea ; Roumiguié, Mathieu ; Kamat, Ashish M...
The Lancet Oncology. 25 (2024) 6 - p. 720-730 , 2024

Link: https://doi.org/10.1016/..

15

TALAPRO-3 Clinical Trial Protocol: Phase III Study of Talaz..:

Agarwal, Neeraj ; Saad, Fred ; Azad, Arun A...
Future Oncology. 20 (2024) 9 - p. 493-505 , 2024

Link: https://doi.org/10.2217/..